Kyriaki Manousou

Postgraduate Course Of Science Of Stress And Health Promotion
Athens, ESYE31 11527, Greece

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Daratumumab-based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study.

Daratumumab-based quadruplet for patients with extramedullary multiple myeloma: Results from the Phase II prospective EMN19 study.

Journal: HemaSphere
Published: July 18, 2025

Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA.

Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA.

Journal: American journal of hematology
Published: November 12, 2023

Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study.

Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study.

Journal: American journal of hematology
Published: March 29, 2023

Educational Stress among Greek Adolescents: Associations between Individual, Study and School-Related Factors.

Educational Stress among Greek Adolescents: Associations between Individual, Study and School-Related Factors.

Journal: International journal of environmental research and public health
Published: November 28, 2022

Reliability and Validity of the Educational Stress Scale for Adolescents (ESSA) in a Sample of Greek Students.

Reliability and Validity of the Educational Stress Scale for Adolescents (ESSA) in a Sample of Greek Students.

Journal: Children (Basel, Switzerland)
Published: November 28, 2022

Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD".

Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD".

Journal: Cancers
Published: April 26, 2022

Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer.

Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer.

Journal: Cancer management and research
Published: July 12, 2019

Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?

Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?

Journal: Cancer immunology, immunotherapy : CII
Published: May 17, 2019

The Role of CXCL13 and CXCL9 in Early Breast Cancer.

The Role of CXCL13 and CXCL9 in Early Breast Cancer.

Journal: Clinical breast cancer
Published: April 25, 2019

Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer.

Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer.

Journal: Anticancer research
Published: February 14, 2019

Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.

Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.

Journal: Clinical breast cancer
Published: February 13, 2019

Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer.

Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer.

Journal: Cancer genomics & proteomics
Published: February 11, 2019
Showing 1-12 of 23

Last Updated: 09/26/2026